Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 5;12(11):e0108124.
doi: 10.1128/spectrum.01081-24. Epub 2024 Sep 25.

Polymicrobial methicillin-resistant Staphylococcus aureus bloodstream infections

Angelica Escalona #  1 , Emi Hayashi #  1 , Michelle Evans  1 , Harm van Bakel  2   3   4   5 , Bremy Alburquerque  2 , Amy C Dupper  1 , Russell McBride  6 , Deena R Altman  1   2
Affiliations

Polymicrobial methicillin-resistant Staphylococcus aureus bloodstream infections

Angelica Escalona et al. Microbiol Spectr. .

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) is a serious public health concern. At times, MRSA is isolated from the blood along with other pathogens, the significance and consequences of which are not well described. This study aims to outline the clinical characteristics and outcomes of those with polymicrobial MRSA BSI compared with those with monomicrobial MRSA BSI. We conducted a retrospective case-control study of those with and without polymicrobial MRSA BSI from 2014 to 2022 at a single quaternary care center in New York City. Risk factors and outcomes for polymicrobial MRSA BSI were assessed using logistic regression analyses. Of 559 patients with MRSA BSI during the study period, 49 (9%) had polymicrobial MRSA BSI. Gram-positive Enterococcus (23%) was the most common co-pathogen. The presence of urinary (P = 0.02) and gastrointestinal (P < 0.01) devices was significantly associated with polymicrobial MRSA BSI. Polymicrobial MRSA BSI was associated with intensive care unit (ICU) admission after BSI (P = 0.01). Mortality did not differ. While polymicrobial MRSA BSI is relatively uncommon, it complicates an already complex clinical scenario of MRSA BSI.IMPORTANCEStaphylococcus aureus is a common human pathogen associated with severe disease and high mortality rates. Although clinically observed, little is known about the impact of polymicrobial staphylococcal bloodstream infection. This study evaluates polymicrobial methicillin-resistant S. aureus bloodstream infection (BSI), highlighting the increased risk of intensive care unit admission and impact on morbidity. Identifying risk factors for polymicrobial BSI, such as the presence of specific devices, can aid in early recognition and targeted interventions. Clarifying the risks and outcomes of polymicrobial infections can lead to strategies to minimize and manage these infections and explore the potential interactions between pathogens.

Keywords: Staphylococcus aureus; bacteremia; bloodstream infections.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig 1
Fig 1
Flowchat outlining the selection of cases and controls with predefined inclusion and exclusion criteria.
See this image and copyright information in PMC

References

    1. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520–532. doi:10.1056/NEJM199808203390806 - DOI - PubMed
    1. Dupper AC, Sullivan MJ, Chacko KI, Mishkin A, Ciferri B, Kumaresh A, Berbel Caban A, Oussenko I, Beckford C, Zeitouni NE, Sebra R, Hamula C, Smith M, Kasarskis A, Patel G, McBride RB, van Bakel H, Altman DR. 2019. Blurred molecular epidemiological lines between the two dominant methicillin-resistant Staphylococcus aureus clones. Open Forum Infect Dis 6:fz302. doi:10.1093/ofid/ofz302 - DOI - PMC - PubMed
    1. Pavlaki M, Poulakou G, Drimousis P, Adamis G, Apostolidou E, Gatselis NK, Kritselis I, Mega A, Mylona V, Papatsoris A, Pappas A, Prekates A, Raftogiannis M, Rigaki K, Sereti K, Sinapidis D, Tsangaris I, Tzanetakou V, Veldekis D, Mandragos K, Giamarellou H, Dimopoulos G. 2013. Polymicrobial bloodstream infections: epidemiology and impact on mortality. J Glob Antimicrob Resist 1:207–212. doi:10.1016/j.jgar.2013.06.005 - DOI - PubMed
    1. Kiani D, Quinn EL, Burch KH, Madhavan T, Saravolatz LD, Neblett TR. 1979. The increasing importance of polymicrobial bacteremia. JAMA 242:1044–1047. doi:10.1001/jama.1979.03300100022015 - DOI - PubMed
    1. Zheng C, Zhang S, Chen Q, Zhong L, Huang T, Zhang X, Zhang K, Zhou H, Cai J, Du L, Wang C, Cui W, Zhang G. 2020. Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections. Antimicrob Resist Infect Control 9:76. doi:10.1186/s13756-020-00741-6 - DOI - PMC - PubMed

MeSH terms

Substances